Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a **combination of two essential water-soluble vitamins**: riboflavin (vitamin B2) and vitamin C (ascorbic acid). Both play important roles as dietary supplements and are often found together in multivitamin and B-complex formulations. - **Riboflavin** acts primarily as a precursor for cofactors (FAD and FMN) involved in cellular energy metabolism, redox reactions, and antioxidant defense[5]. - **Vitamin C** is a major extracellular antioxidant that protects cells against oxidative stress by neutralizing free radicals and acts as a cofactor for several biosynthetic enzymes[5]. The combination is often indicated for the prevention or treatment of vitamin deficiency due to poor diet, illness, alcoholism, or pregnancy. There is evidence for potential *synergistic protection against oxidative stress and organ injury* when both vitamins are administered together[5]. These nutrients are frequently components of over-the-counter multivitamin and B-complex with vitamin C supplements[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on riboflavin + vitamin C.